Lin Y, Lin X, Xia R, Chen J, et al. Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy. PLoS One 2025;20:e0327298.
PMID: 40644379